FDC Drugs: Delhi High Court sets aside ban on Wockhardt's anti-inflammatory drugJanuary 7 2019
In one of several challenges to the ban on the manufacture, sale or distribution of 328 Fixed Dose Combination (FDC) drugs in India, the Delhi High Court today set aside the Centre's decision to ban an FDC manufactured by Wockhardt Ltd.
The said FDC is a formulation of Aceclofenac + Paracetamol + Rabeprazol, and is sold under the brand name ‘Ace Proxyvon Tablet 10 T’. The FDC is typically . . .
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports